Health Care & Life Sciences » Pharmaceuticals | Ohr Pharmaceutical Inc.

Ohr Pharmaceutical Inc.

Ohr Pharmaceutical Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
56.47 M
Public Float
51.43 M
Ohr Pharmaceutical Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.17
Market Cap
$10.47 M
Shares Outstanding
2.83 M
Public Float
2.69 M

Profile

Address
800 Third Avenue
New York New York 10022
United States
Employees -
Website http://www.ohrpharmaceutical.com
Updated 07/08/2019
Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B.

Financials

View All

Michael Ferguson
Chairman
Jason Scott Slakter
President, Chief Executive Officer & Director